Abstract

Bioabsorbable Mg and alloys have been used as metallic biomaterials for orthopedic implant applications due to their similar mechanical properties to human natural bone. High biodegradation rate is the main reason for limiting clinical applications of Mg and alloys in biological media. In order to achieve long-lasting bio applications of bioabsorbable WE43 Mg alloy, it is necessary to improve strength and bioactivity and control biodegradation rate of this material. In this study, Mg-based biocomposites are produced using friction stir processing (FSP) by addition of wollastonite (CaSiO3) calcium-silicate-based bioactive reinforcing particle into Mg matrix. The results showed that applied severe plastic deformation during FSP caused formation of ultra-fine grain structure with homogenous distribution of secondary phase particles, which resulted in a remarkable improvement of ductility, strength and load bearing capacity of FSPed Mg matrix. Also, biodegradation behavior of resulting biocomposite was evaluated using electrochemical methods and in-vitro immersion test in simulated body fluid (SBF) and phosphate-buffered saline (PBS) at 37.5 °C. The results revealed that processed bioabsorbable Mg alloy showed a lower biodegradation rate compared to monolithic Mg alloy. Furthermore, the presence of wollastonite bioceramic particles significantly enhanced strength and reduced biodegradation of the Mg-based biocomposite. Moreover, the addition of wollastonite bioceramic particles positively affected the bioactivity of Mg matrix by forming a cauliflower shaped bone-like hydroxyapatite layer on the surface after 28 days of immersion in SBF and stimulate bone tissue regeneration.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call